These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

250 related articles for article (PubMed ID: 7523113)

  • 41. Requirement of an ICE/CED-3 protease for Fas/APO-1-mediated apoptosis.
    Los M; Van de Craen M; Penning LC; Schenk H; Westendorp M; Baeuerle PA; Dröge W; Krammer PH; Fiers W; Schulze-Osthoff K
    Nature; 1995 May; 375(6526):81-3. PubMed ID: 7536901
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Induction of apoptosis by Apo-2 ligand, a new member of the tumor necrosis factor cytokine family.
    Pitti RM; Marsters SA; Ruppert S; Donahue CJ; Moore A; Ashkenazi A
    J Biol Chem; 1996 May; 271(22):12687-90. PubMed ID: 8663110
    [TBL] [Abstract][Full Text] [Related]  

  • 43. NF-kappaB stimulates inducible nitric oxide synthase to protect mouse hepatocytes from TNF-alpha- and Fas-mediated apoptosis.
    Hatano E; Bennett BL; Manning AM; Qian T; Lemasters JJ; Brenner DA
    Gastroenterology; 2001 Apr; 120(5):1251-62. PubMed ID: 11266388
    [TBL] [Abstract][Full Text] [Related]  

  • 44. A20 protects endothelial cells from TNF-, Fas-, and NK-mediated cell death by inhibiting caspase 8 activation.
    Daniel S; Arvelo MB; Patel VI; Longo CR; Shrikhande G; Shukri T; Mahiou J; Sun DW; Mottley C; Grey ST; Ferran C
    Blood; 2004 Oct; 104(8):2376-84. PubMed ID: 15251990
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Overexpression of the p80 TNF receptor leads to TNF-dependent apoptosis, nuclear factor-kappa B activation, and c-Jun kinase activation.
    Haridas V; Darnay BG; Natarajan K; Heller R; Aggarwal BB
    J Immunol; 1998 Apr; 160(7):3152-62. PubMed ID: 9531270
    [TBL] [Abstract][Full Text] [Related]  

  • 46. NF-kappaB regulates Fas/APO-1/CD95- and TCR- mediated apoptosis of T lymphocytes.
    Dudley E; Hornung F; Zheng L; Scherer D; Ballard D; Lenardo M
    Eur J Immunol; 1999 Mar; 29(3):878-86. PubMed ID: 10092091
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Structural determinants of DISC function: new insights into death receptor-mediated apoptosis signalling.
    Sessler T; Healy S; Samali A; Szegezdi E
    Pharmacol Ther; 2013 Nov; 140(2):186-99. PubMed ID: 23845861
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Death the Fas way: regulation and pathophysiology of CD95 and its ligand.
    Sharma K; Wang RX; Zhang LY; Yin DL; Luo XY; Solomon JC; Jiang RF; Markos K; Davidson W; Scott DW; Shi YF
    Pharmacol Ther; 2000 Dec; 88(3):333-47. PubMed ID: 11337030
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Bcl-2 and Fas/APO-1 regulate distinct pathways to lymphocyte apoptosis.
    Strasser A; Harris AW; Huang DC; Krammer PH; Cory S
    EMBO J; 1995 Dec; 14(24):6136-47. PubMed ID: 8557033
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Fas/APO-1 gene transfer for human malignant glioma.
    Weller M; Malipiero U; Rensing-Ehl A; Barr PJ; Fontana A
    Cancer Res; 1995 Jul; 55(13):2936-44. PubMed ID: 7540953
    [TBL] [Abstract][Full Text] [Related]  

  • 51. A three-dimensional model of the Fas/APO-1 molecule: cross-reactivity of anti-Fas antibodies explained by structural mimicry of antigenic sites.
    Fadeel B; Lindberg J; Achour A; Chiodi F
    Int Immunol; 1998 Feb; 10(2):131-40. PubMed ID: 9533440
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The ability of BHRF1 to inhibit apoptosis is dependent on stimulus and cell type.
    Foghsgaard L; Jäättelä M
    J Virol; 1997 Oct; 71(10):7509-17. PubMed ID: 9311830
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Dendritic cells are resistant to apoptosis through the Fas (CD95/APO-1) pathway.
    Ashany D; Savir A; Bhardwaj N; Elkon KB
    J Immunol; 1999 Nov; 163(10):5303-11. PubMed ID: 10553053
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Protein Kinase-Mediated Decision Between the Life and Death.
    Engin A
    Adv Exp Med Biol; 2021; 1275():1-33. PubMed ID: 33539010
    [TBL] [Abstract][Full Text] [Related]  

  • 55. alpha-fetoprotein causes apoptosis in tumor cells via a pathway independent of CD95, TNFR1 and TNFR2 through activation of caspase-3-like proteases.
    Dudich E; Semenkova L; Dudich I; Gorbatova E; Tochtamisheva N; Tatulov E; Nikolaeva M; Sukhikh G
    Eur J Biochem; 1999 Dec; 266(3):750-61. PubMed ID: 10583368
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Myeloma cells express Fas antigen/APO-1 (CD95) but only some are sensitive to anti-Fas antibody resulting in apoptosis.
    Shima Y; Nishimoto N; Ogata A; Fujii Y; Yoshizaki K; Kishimoto T
    Blood; 1995 Feb; 85(3):757-64. PubMed ID: 7530506
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Reactive nitrogen species-induced cell death requires Fas-dependent activation of c-Jun N-terminal kinase.
    Shrivastava P; Pantano C; Watkin R; McElhinney B; Guala A; Poynter ML; Persinger RL; Budd R; Janssen-Heininger Y
    Mol Cell Biol; 2004 Aug; 24(15):6763-72. PubMed ID: 15254243
    [TBL] [Abstract][Full Text] [Related]  

  • 58. NF kappa B controls the balance between Fas and tumor necrosis factor cell death pathways during T cell receptor-induced apoptosis via the expression of its target gene A20.
    Malewicz M; Zeller N; Yilmaz ZB; Weih F
    J Biol Chem; 2003 Aug; 278(35):32825-33. PubMed ID: 12813034
    [TBL] [Abstract][Full Text] [Related]  

  • 59. A dual role for both CD40-ligand and TNF-alpha in controlling human B cell death.
    Lens SM; Tesselaar K; den Drijver BF; van Oers MH; van Lier RA
    J Immunol; 1996 Jan; 156(2):507-14. PubMed ID: 8543800
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Non-apoptotic Fas signaling.
    Wajant H; Pfizenmaier K; Scheurich P
    Cytokine Growth Factor Rev; 2003 Feb; 14(1):53-66. PubMed ID: 12485619
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.